The release of the LEAP study’s findings that having at-risk infants consume peanut protein can, in a majority of cases, teach the immune system tolerance and prevent allergy has led to some confusion. In light of questions that have followed the AAAAI meeting announcement of these results, we turned to the experts to address two […]
Testing OIT in such a young population has never been done before, but results show that it’s worth it.
The LEAP study, which found that feeding peanut to young infants with heightened allergy risk reduces the odds that a peanut allergy will develop by 70 to 80 percent, involved in-depth research on hundreds of children from infancy to 5 years of age. The results were published in The New England Journal of Medicine. Key points […]
The AAAAI annual meeting is a hub of scientific breakthroughs and new treatments. Here are the highlights from the 2015 conference.
In trials, Viaskin Peanut allowed some participants to tolerate 10 times more peanut protein than at the outset.
Chance of developing peanut allergy reduced 70 to 80 percent in high-risk babies. New guidelines expected.
Emergency auto-injectors were used in more than 900 cases of anaphylaxis in U.S. schools last academic year.
The FDA is advising people who are highly allergic to peanuts to consider avoiding products that contain ground cumin or cumin powder.